Unity Biotechnology Inc (UBX) stock is lower by -60.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives UBX stock a score of 32 out of a possible 100.
That rank is influenced by a short-term technical score of 9. UBX's rank also includes a long-term technical score of 10. UBX has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on UBX!